{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T05:55:44Z","timestamp":1725688544007},"reference-count":33,"publisher":"Japanese Society for Hygiene","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Environ Health Prev Med","Environ. Health Prev. Med."],"published-print":{"date-parts":[[2024]]},"DOI":"10.1265\/ehpm.23-00245","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T22:12:31Z","timestamp":1716243151000},"page":"30-30","source":"Crossref","is-referenced-by-count":1,"title":["Identification and analysis of differently expressed transcription factors in aristolochic acid nephropathy"],"prefix":"10.1265","volume":"29","author":[{"given":"Yi-Feng","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The Third Xiangya Hospital, Central South University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Yao","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Third Xiangya Hospital, Central South University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Xuan","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Third Xiangya Hospital, Central South University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Third Xiangya Hospital, Central South University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Rui","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Third Xiangya Hospital, Central South University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-Liang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Third Xiangya Hospital, Central South University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jie","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Third Xiangya Hospital, Central South University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Qing","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Third Xiangya Hospital, Central South University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Yun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Third Xiangya Hospital, Central South University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Cong","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Third Xiangya Hospital, Central South University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"335","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Jadot I, et al. An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature. Int J Mol Sci. 2017;18(2).","DOI":"10.3390\/ijms18020297"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Stiborova M, et al. Enzymes metabolizing aristolochic acid and their contribution to the development of aristolochic acid nephropathy and urothelial cancer. Curr Drug Metab. 2013;14(6):695\u2013705.","DOI":"10.2174\/1389200211314060006"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Int. 2008;74(2):158\u201369.","DOI":"10.1038\/ki.2008.129"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Luciano RL, Perazella MA. Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment. Drug Saf. 2015;38(1):55\u201364.","DOI":"10.1007\/s40264-014-0244-x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kocic G, et al. Purine adducts as a presumable missing link for aristolochic acid nephropathy-related cellular energy crisis, potential anti-fibrotic prevention and treatment. Br J Pharmacol. 2021;178(22):4411\u201327.","DOI":"10.1111\/bph.15618"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shi M, et al. Renal Protective Effects of 17beta-Estradiol on Mice with Acute Aristolochic Acid Nephropathy. Molecules. 2016;21(10).","DOI":"10.3390\/molecules21101391"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Vanherweghem JL, et al. Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy. Am J Kidney Dis. 1996;27(2):209\u201315.","DOI":"10.1016\/S0272-6386(96)90542-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gokmen MR, et al. The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review. Ann Intern Med. 2013;158(6):469\u201377.","DOI":"10.7326\/0003-4819-158-6-201303190-00006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Anger EE, Yu F, Li J. Aristolochic Acid-Induced Nephrotoxicity: Molecular Mechanisms and Potential Protective Approaches. Int J Mol Sci. 2020;21(3).","DOI":"10.3390\/ijms21031157"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Francois M, Donovan P, Fontaine F. Modulating transcription factor activity: Interfering with protein-protein interaction networks. Semin Cell Dev Biol. 2020;99:12\u20139.","DOI":"10.1016\/j.semcdb.2018.07.019"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zhu L, et al. Activation of TFEB-mediated autophagy by trehalose attenuates mitochondrial dysfunction in cisplatin-induced acute kidney injury. Theranostics. 2020;10(13):5829\u201344.","DOI":"10.7150\/thno.44051"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Piret SE, et al. Loss of proximal tubular transcription factor Kruppel-like factor 15 exacerbates kidney injury through loss of fatty acid oxidation. Kidney Int. 2021;100(6):1250\u201367.","DOI":"10.1016\/j.kint.2021.08.031"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Xiao S, et al. Uncovering potential novel biomarkers and immune infiltration characteristics in persistent atrial fibrillation using integrated bioinformatics analysis. Math Biosci Eng. 2021;18(4):4696\u2013712.","DOI":"10.3934\/mbe.2021238"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Chen Z, et al. Prioritization of Diagnostic and Prognostic Biomarkers for Lupus Nephritis Based on Integrated Bioinformatics Analyses. Front Bioeng Biotechnol. 2021;9:717234.","DOI":"10.3389\/fbioe.2021.717234"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Inadera H, et al. Carbon tetrachloride affects inflammation-related biochemical networks in the mouse liver as identified by a customized cDNA microarray system. Environ Health Prev Med. 2010;15(2):105\u201314.","DOI":"10.1007\/s12199-009-0117-6"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yuan Q, Zhang H. Identification of differentially expressed genes and pathways in BEAS-2B cells upon long-term exposure to particulate matter (PM(2.5)) from biomass combustion using bioinformatics analysis. Environ Health Prev Med. 2023;28:51.","DOI":"10.1265\/ehpm.22-00272"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Zhang Q, et al. Dissection of Targeting Molecular Mechanisms of Aristolochic Acid-induced Nephrotoxicity via a Combined Deconvolution Strategy of Chemoproteomics and Metabolomics. Int J Biol Sci. 2022;18(5):2003\u201317.","DOI":"10.7150\/ijbs.69618"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sun J, et al. Melatonin Attenuates Mitochondrial Damage in Aristolochic Acid-Induced Acute Kidney Injury. Biomol Ther (Seoul). 2023;31(1):97\u2013107.","DOI":"10.4062\/biomolther.2022.054"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Zhou Q, et al. Overview of aristolochic acid nephropathy: an update. Kidney Res Clin Pract. 2023.","DOI":"10.23876\/j.krcp.22.211"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Feng C, et al. Protective Effects of Mitochondrial Uncoupling Protein 2 against Aristolochic Acid I-Induced Toxicity in HK-2 Cells. Int J Mol Sci. 2022;23(7).","DOI":"10.3390\/ijms23073674"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lin CE, et al. Proteomics analysis of altered proteins in kidney of mice with aristolochic acid nephropathy using the fluorogenic derivatization-liquid chromatography-tandem mass spectrometry method. Biomed Chromatogr. 2018;32(3).","DOI":"10.1002\/bmc.4127"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Li Y, et al. Integration of transcriptomic, proteomic and metabolomic data to reveal the biological mechanisms of AAI injury in renal epithelial cells. Toxicol In Vitro. 2021;70:105054.","DOI":"10.1016\/j.tiv.2020.105054"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. De Borst MH, et al. Glomerular and tubular induction of the transcription factor c-Jun in human renal disease. J Pathol. 2007;213(2):219\u201328.","DOI":"10.1002\/path.2228"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Yang F, et al. c-Jun Amino Terminal Kinase Signaling Promotes Aristolochic Acid-Induced Acute Kidney Injury. Front Physiol. 2021;12:599114.","DOI":"10.3389\/fphys.2021.599114"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Papavassiliou KA, Papavassiliou AG. Transcription Factor Drug Targets. J Cell Biochem. 2016;117(12):2693\u20136.","DOI":"10.1002\/jcb.25605"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Zhou L, et al. Mechanism of chronic aristolochic acid nephropathy: role of Smad3. Am J Physiol Renal Physiol. 2010;298(4):F1006\u201317.","DOI":"10.1152\/ajprenal.00675.2009"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ren J, et al. The transcription factor Twist1 in the distal nephron but not in macrophages propagates aristolochic acid nephropathy. Kidney Int. 2020;97(1):119\u201329.","DOI":"10.1016\/j.kint.2019.07.016"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Yang T, et al. The potential roles of ATF family in the treatment of Alzheimer\u2019s disease. Biomed Pharmacother. 2023;161:114544.","DOI":"10.1016\/j.biopha.2023.114544"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Ku HC, Cheng CF. Master Regulator Activating Transcription Factor 3 (ATF3) in Metabolic Homeostasis and Cancer. Front Endocrinol (Lausanne). 2020;11:556.","DOI":"10.3389\/fendo.2020.00556"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Zhu B, et al. Formononetin ameliorates ferroptosis-associated fibrosis in renal tubular epithelial cells and in mice with chronic kidney disease by suppressing the Smad3\/ATF3\/SLC7A11 signaling. Life Sci. 2023;315:121331.","DOI":"10.1016\/j.lfs.2022.121331"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Wang Y, et al. Quercetin alleviates acute kidney injury by inhibiting ferroptosis. J Adv Res. 2021;28:231\u201343.","DOI":"10.1016\/j.jare.2020.07.007"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Chen J, et al. Integrated single-cell transcriptomics and proteomics reveal cellular-specific responses and microenvironment remodeling in aristolochic acid nephropathy. JCI Insight. 2022;7(16).","DOI":"10.1172\/jci.insight.157360"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Wang Y, et al. Lycopene attenuates the inflammation and apoptosis in aristolochic acid nephropathy by targeting the Nrf2 antioxidant system. Redox Biol. 2022;57:102494.","DOI":"10.1016\/j.redox.2022.102494"}],"container-title":["Environmental Health and Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ehpm\/29\/0\/29_23-00245\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T05:07:29Z","timestamp":1716613649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ehpm\/29\/0\/29_23-00245\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":33,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1265\/ehpm.23-00245","relation":{},"ISSN":["1342-078X","1347-4715"],"issn-type":[{"value":"1342-078X","type":"print"},{"value":"1347-4715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"23-00245"}}